Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN120574796A enables high-purity (S)-nornicotine production. Discover cost reduction in pharmaceutical intermediates manufacturing and supply chain reliability.
Patent CN105063161B reveals high-purity R-1-aminoindane production. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN103087033A reveals a metal-free synthesis route for oxepin-3(2H)-one derivatives, offering significant cost reduction and supply chain reliability for fine chemical manufacturing.
Patent CN101838315A reveals resin-based purification for Ramoplanin. Achieve high purity and scalable production for reliable pharmaceutical intermediates supplier partnerships.
Patent CN102690333B details a novel nano-polymer chromatography method for teicoplanin, ensuring pharmacopoeial compliance and scalable supply chain reliability for global pharmaceutical manufacturers.
Patent CN101244994A details a high-purity synthesis route for 2,4,5-trifluorophenylacetic acid, offering significant supply chain and cost advantages for Sitagliptin manufacturing.
Advanced fermentation and resin purification method for echinocandin FR179642. Ensures high purity and scalable supply for global antifungal drug production.
Patent CN114805447B details a novel iridium complex photosensitizer enabling mitochondrial targeting and hypoxia-resistant photodynamic therapy with scalable synthesis.
Patent CN105440049B reveals a scalable oxidation method for high-purity milbemycin oxime, offering significant cost reduction and supply chain reliability for veterinary drug manufacturers.
This patent details a resin-based separation method for Partricin A ensuring high purity and reduced solvent usage suitable for large scale pharmaceutical manufacturing supply chains.
Novel nitration-bromination-deamination route for 2-bromo-3-fluorobenzoic acid. Cost-effective, scalable pharma intermediate manufacturing with high purity.
Patent CN113045532A reveals a high-yield route for S-flurbiprofen intermediates. Discover cost-effective manufacturing and scalable supply chain solutions.
Novel resin and nano-microsphere chromatography method ensures greater than 98.5 percent purity. Scalable process reduces costs for antibiotic manufacturing supply chains globally.
Patent CN117402055A enables efficient recycling of mother liquor into high-purity m-fluorobenzoic acid. This process offers substantial cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN106928162B reveals a solvent-free synthesis method for N-phenylmorpholine compounds, offering significant cost reduction and high yield for pharmaceutical intermediates manufacturing.
Patent CN115341009B details enzyme solution reuse for steroid synthesis. Reduces cost and improves yield for pharmaceutical intermediates manufacturing supply chains.
Novel ketoreductase method for S-1-BOC-3 hydroxypiperidine ensures high purity and supply continuity. Reduce costs in API manufacturing with scalable enzymatic routes.
Patent CN119504908A reveals a novel purification method reducing free fatty acids. Achieve high-purity dexamethasone palmitate with significant cost reduction and supply chain reliability.
Patent CN100503627C details a novel resin-assisted method for troxerutin, offering superior purity and reduced heavy metals for reliable supply chains.
Patent CN116024284A reveals mutant imine reductase for S-nicotine. Achieve >99% ee and high conversion. Reliable pharmaceutical intermediate supplier for cost reduction.